Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 43464

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2022 | Month : April | Volume : 16 | Issue : 4 | Page : EC23 - EC27 Full Version

Prognostic Importance of Red Cell Distribution Width, Mean Platelet Volume and Neutrophil Lymphocyte Ratio among Sepsis Patients at a Tertiary Setting in Kolar, South India


Published: April 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/52240.16203
Minni Meka, A Raveesha, R Kalyani

1. Senior Resident, Department of General Medicine, SDUMC, Bangalore, Karnataka, India. 2. Professor and Head, Department of General Medicine, SDUMC, Bangalore, Karnataka, India. 3. Professor and Head. Department of Pathology, SDUMC, Bangalore, Karnataka, India.

Correspondence Address :
Dr. A Raveesha,
201, Sai Krupa Heera, 1st Main, Bhuvaneshwari Nagar, C.V. Raman Nagar, Bangalore, Karnataka, India.
E-mail: docraveesh@gmail.com

Abstract

Introduction: Complete Blood Count (CBC) analysis contain several parameters that are routinely investigated during admission. Of these parameters, Red-Cell Distribution Width (RDW), Mean Platelet Volume (MPV), Neutrophil-Lymphocyte Ratio (NLR) have been observed as independent risk factors for various systemic diseases.

Aim: To compare the prognostic value of RDW, MPV, NLR with Sequential Organ Failure Assessment (SOFA) score among sepsis survivors and non survivors.

Materials and Methods: A prospective observational study was conducted among 120 sepsis patients admitted in department of General Medicine and Intensive Care Unit (ICU) at a tertiary care and research center in Kolar, South India, for 18 months from January 2018 to July 2019. Patients information regarding age, gender, SOFA scores, and parameters like RDW, MPV, NLR were recorded from the blood sample. The SOFA score, RDW, NLR, and MPV levels were considered explanatory variables for sepsis patients’ mortality. To test significance, independent t-test and Chi-square test were used. Correlation analysis was performed with the pearson correlation coefficient. The SOFA score, RDW, MPV, and NLR were further analysed using the receiver operating characteristic (ROC). The level of significance was set at ≤0.05. coGuide software, V.1. was used for data analysis.

Results: All 120 subjects were divided into two groups. Survivor’s group had 79 (65.8%) subjects, and 41 (34%) were in non-survivor’s groups. Most of the survivors were in the age group 60-79 years which were 29 (36.71%), whereas non survivors were 40-59 years which were 17 (41.46%). Maximum were males in both the groups. Fever was the most common presenting symptom in survivors, 62 (78.48%) and non survivors 31 (75.61%). The calculated Area Under Curve (AUC) for RDW was 0.973 with 90.24% sensitivity and 97.47% specificity. The AUC for MPV was 0.966 with 92.68% sensitivity and 97.47% specificity, and for NLR, it was 0.984 with 100% sensitivity and 89.87% specificity. The yielded AUC for SOFA score was 0.772 with 56.10% sensitivity and 89.87% specificity. Ventilator and ionotropic support were strongly associated between groups (p-value <0.001). There was a significant difference among survivors and non survivors for SOFA score (p-value <0.001), systolic and diastolic blood pressure, pulse rate, GCS, and investigations like RDW, NLR, and MPV (p-value <0.001).

Conclusion: This study demonstrated a strong correlation between increased levels of RDW, NLR, MPV and mortality among sepsis patients and can be used as prognostic markers for mortality prediction in adult sepsis patients.

Keywords

Biomarkers, Complete blood analysis, Inflammatory marker, Systemic inflammation, Ventilation

Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection. It is usually manifested as systemic inflammatory response syndrome (SIRS) to the causative infection. Worldwide, there is an increase in incidence of sepsis and septic shock (1). Sepsis has become a life-threatening burden to public health, due to increased mortality in intensive care units (2). In 2017, approximately 11.0 million deaths were reported globally, and in the past few years, there has been a decreasing trend in incidence and mortality due to sepsis (3). Systemic inflammation, tissue hypoperfusion, organ dysfunction, and immune disorder are common manifestations of sepsis due to infections (4).

Pathogenesis of sepsis includes tissues, cell types, organ systems, and many inflammatory mediators, involving release of many biomarkers, that suggests role of biomarkers in sepsis management. Nearly 180 molecules were proposed as sepsis biomarkers (5). These physiological changes influence Complete Blood Count (CBC). Red cell distribution width (RDW), Mean Platelet Volume (MPV), and Neutrophil-Lymphocyte Ratio (NLR) are parameters obtained from routine CBC (6).

For diagnosing sepsis, complete blood culture is the standard method and takes around two to five days in identifying the bacterial or fungal growth in blood culture (7). If sepsis is suspected, other tests such as CBC, biochemical assays, and C-Reactive Protein (CRP) levels are conducted with blood culture. From a patient’s haemogram, simple haematological parameters can be calculated easily (8). An increasing number of studies have evaluated the association between RDW, MPV, NLR, and mortality rates or other complications in various disease states, such as heart failure and critical illness, trauma, and sepsis (9),(10),(11).

Higher mortality and morbidity levels in sepsis leads to an economic burden at both individual and community level. Mortality from sepsis remains unacceptably high, even after the many advances in antimicrobial agents and supportive care. Due to its varied etiologies and variable prognoses, sepsis patients are the most complex patients encountered in medical practice. To increase sepsis patient’s quality of care, mortality prediction models utilizing available resources optimally need to be developed. In past decades many scoring models like Acute Physiology, Age and Chronic Health Evaluation (APACHE), Simplified Acute Physiology (SAPS), Mortality and Prediction Model (MPM), Multiple Organ Dysfunction (MOD), Open Data Inventory (ODIN), SOFA, Change Impact Score (CIS) etc have been developed to predict the outcome of admitted sepsis patients. The ICU resources are less in developing world and utilisation of this scoring system results in timely management od sepsis patients (12).

Literature on diagnostic and early treatment of sepsis is majorly from developed countries. Research is still going on for the identification of markers to diagnose sepsis, severe sepsis, and septic shock. Extensive research to identify biomarkers for sepsis is needed from developing countries like India. Automated analysers are used to test CBC in most sepsis patients admitted to the emergency medical services. These automated analysers provide RDW, NLR, MPV which are routinely provided within the CBC. Inexpensive, routinely available, and rapidly measurable prognostic tools have clinical utility in the identification of a subset of patients with severe sepsis who need aggressive management. Therefore, the present study sought to evaluate the prognostic efficiency of RDW, the NLR, MPV in evaluating sepsis severity. The aim of this study was to compare the prognostic significance of RDW, MPV, NLR, and SOFA score with clinical outcome (survivors and non survivors) among sepsis patients.

Material and Methods

A prospective observational study was conducted for a period of 18 months from January 2018 to July 2019 in Department of General Medicine and ICU at tertiary care and research center in South India. Sepsis patients admitted to the General Medicine, and ICU department was considered the study population. Approval was obtained from the Institutional Ethical Committee of the concerned tertiary care setting. (Number-SDUMC/KLR/IEC/08/
2017-18). All participants gave written informed consent. Confidentiality of the study subjects was maintained throughout.

Sample size calculation: The sample size was calculated assuming the expected Area Under Receiver Operating Curve (ROC) curve for the SOFA scoring system in predicting mortality as 0.78 as per Kim YC et al., the null hypothesis value of area under ROC curve was considered 0.5, the ratio of sample size is in the negative and positive group was considered as 1:2 (13). The other parameters considered for the sample size calculation included a 5% alpha error and 99% study power. As per the calculation mentioned above, the required sample size was 66 as 44 were positive, and 22 were negative. To account for the non participation, rate/absence of about 20%, another 8 & 4 subjects were added to the sample, respectively. Hence, the final required sample size was 52 and 26 in each positive and negative groups. In the end, it was considered 79 and 41 subjects in positive and negative groups. Sample size calculation was done using coGuide software. For the feasibility of the study, all 120 subjects were selected according to the universal sampling method.

Inclusion criteria: Patients >18 years of age with sepsis (diagnosed as per “The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)” (4). Sepsis should be defined as life threatening organ dysfunction caused by a dysregulated host response to infection. For clinical operationalization, organ dysfunction can be represented by an increase in the Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score of 2 points or more, which is associated with an in-hospital mortality greater than 10%.

Exclusion criteria: Before infection, patients with pre-existing organ dysfunction (chronic kidney disease, decompensated liver disease, cardiac disease), patients with blood loss >10% blood volume, who had blood product transfusion in the week before admission were excluded from the study. In addition patients with haematological diseases such as anaemia, hypersplenism, haematological malignancy, metastatic bone marrow infiltration by malignancy, recovery after bone marrow hyperplasia, patients who had undergone recent chemotherapy and pregnant individuals were excluded from the study.

The parameters evaluated were: demographic data, co-morbidities, clinical findings at the time of admission, microorganism proliferation in the wound culture, laboratory findings (MPV, RDW, NLR), recorded at admission and within 24 hours after ICU admission.RDW to platelet count ratio (RPR) was also calculated. However, only RDW, MPV, NLR, and SOFA scores were assessed in the present study.

Study Procedure

Venous blood (3 mL) was collected from patients into an Ethylenediaminetetraacetic Acid (EDTA) containing tube and centrifuged at 3,000 rpm for 15 minutes, by automated CBC analyser “Cell Dyne Ruby” (Abbott, Diagnostic ®). The RDW, NLR, MPV values were obtained as part of the CBC results. RDW was calculated by dividing the standard deviation (SD) of the Mean Corpuscular Volume (MCV) and multiplying by 100, which is a percentage on behalf of the RBC size heterogeneity. NLR is calculated by dividing number of neutrophils with number of lymphocytes. Increased neutrophils and decreased lymphocytes count is seen during stress which is a physiological immune response of leucocytes. An objective parameter MPV is used to determine platelet size.

Simple and objective SOFA score measures individual or aggregate organ dysfunction in six organ systems (respiratory, coagulatory, liver, cardiovascular, renal, and neurologic). The parameters used to calculate the SOFA score are PaO2/FiO2, platelet count, bilirubin, blood pressure, inotropic agent, a Glasgow Coma Score Scale (GCS), and creatinine or urine output.

Normal function is scored 0 for patient without previously known co-morbidity like cirrhosis, chronic kidney disease. Score 4 was given for the most abnormal condition giving a possible score of 0 to 24 on each day of ICU stay. Maximal SOFA score is sum of the highest score per individual during the entire ICU stay. A higher SOFA score increases the probability of mortality. A SOFA score >15 predicts mortality of 90% (10),(14),(15). The SOFA score was recorded at admission. All patients were followed-up at the hospital until discharge, death, or a maximum of 14 days. Data of patients requiring inotropic and ventilator support, renal replacement therapy for adverse events was recorded. Mortality was considered the primary outcome variable. Ventilator support, ionotropic support, renal replacement was considered as secondary outcome variables. SOFA score, RDW, NLR, and MPV levels were considered explanatory variables for sepsis patient’s mortality.

Statistical Analysis

Mean and standard deviation was used to represent continuous data and frequencies and proportions for categorical data. To test the mean difference between two quantitative variables, an independent t-test was used and Chi-square test or Fischer’s exact test was used for qualitative data. Correlations were performed with pearson correlation coefficient SOFA score, RDW, MPV, and NLR were further analysed using the ROC, and optimal cut-off points were chosen for the calculation of sensitivity, specificity. ROC of 0.5 predicts an outcome better than chance. An area under the ROC was a fairly good prediction when it was >0.8 p-value was set at ≤0.05. coGuide software, V.1. was used for data analysis (16).

Results

All 120 subjects were sorted into two groups. Survivors group had 79 (65.8%) subjects, and 41 (34%) were in non-survivor’s groups. Most of the survivors were in the age group 60-79 years 29 (36.71%). In contrast, non survivors fall into 40-59 years majorly with 41.46% (17 out of 41). No significant difference was seen with age between the study group (p>0.05). Most of the 41 (51.9%) participants were male among survivors and non survivors 27 (65.85%). Symptoms such as fever, cough, breathlessness, altered sensorium, vomiting, and abdominal pain between survivors and non survivors were insignificant (Table/Fig 1).

Survivors and non survivors were commonly diagnosed with lower respiratory tract infections and lower respiratory tract infections with acute respiratory distress syndrome and the association was significant between groups (p<0.005) Urosepsis, acute gastroenteritis and other diagnosis, cultured organisms, and co-morbidities were not associated significantly between survivors and non survivors (Table/Fig 2).

Out of 79 survivors, 29 (36.71%) were on ventilator support, 42 (53.16%) were on inotropic support. Out of 41 non survivors, 40 (97.56%) had ventilator support, and 38 (92.68%) had inotropic support and the association was significant (p-value <0.001). The association was significant with respect to SOFA Score (p-value <0.001) Systolic Blood Pressure (SBP) (mm/hg), Diastolic Blood Pressure (DBP) (mm/hg), pulse (bpm), GCS and investigations like RDW, NLR and MPV (p-value <0.001). No significant difference was seen between the study group in RPR (p-value 0.784) (Table/Fig 3).

A positive correlation was found between SOFA score and RDW (r=0.465; p<0.001), NLR (r=0.318; p<0.001), MPV (r=0.400; p<0.001) (Table/Fig 4).

The calculated AUC for RDW was 0.973 with >15.2 as cut-off and 90.24% sensitivity, and 97.47% specificity. The yielded AUC for MPV was 0.966 with >9.4 as cut-off, and 92.68% sensitivity and 97.47% specificity. The AUC for NLR was 0.984 with >10.1 as cut-off and 100% sensitivity and 89.87% specificity. The predictive validity of SOFA, RDW, MPV, NLR in predicting survival (ROC analysis) was explained in (Table/Fig 5).

Discussion

This prospective observational Study assessed prognostic importance of RDW, MPV and NLR among patients with sepsis, aiming to help clinicians in sepsis recognition and risk stratification. Most of the survivors were in the age group 60-79 years (36.71%), whereas most non survivors were in 40-59 years (41.46%). Most of the participants were males among survivors and non survivors. This finding was in comparison to a retrospective examination by Gozdas HT et al., in Turkey, where the mean age was 69.8±16.2, and 74 (61.2%) were male participants out of 121 (8). In the present study, the SOFA score in non survivors was 9±3, which was more than survivors 5±3, and the association was significant. The finding was similar to a multicentric study by Lie KC et al., in Southeast Asia among 454 adult patients with community-acquired sepsis (17). There was significantly higher total SOFA score during admission among non survivors than survivors (6.7 vs. 4.6, p<0.001**).

In the current study, RDW level was more in non survivors, 16.20±0.81, compared to survivors, 14.37±0.62, and the association was significant (p<0.001**). Krishna V et al., in South India, found higher levels of RDW in 30 (50%) out of 60 patients and a lesser levels of RDW in 30 (50%) patients and significant association was found between mortality and levels of RDW (p<0.05) (18). Kim YC et al., in China reported RDW, platelet count, and delta neutrophil index as predictor for 28- day patient mortality (13). The NLR value was more in non survivors 12.09±1.04 compared to survivors 8.79±0.65, and the association was significant (p<0.001**). The finding was similar to a cross-sectional study by Gupta A et al., in Jabalpur, India, among 117 patients with sepsis reported significant statistical difference in the mean and SD of NLR, RDW-SD, PLT, and Platelet Crit (PCT) on day one and day seven of observation (19). Another ICU cross-sectional study by Pavan et al., in South India found the mean RDW was 14.455 and the mean NLR was 5.1645, and both parameters showed a significant correlation with SOFA score and outcome of sepsis patients (20). Liu X et al., in China found NLR levels, independently associated with unfavorable clinical prognosis in patients with sepsis (21). The MPV level was more in non survivors 10.41±0.74 compared to survivors 8.65±0.64 and the association was significant (p<0.001). This finding was in comparison to a prospective analysis by Orfanu A et al., in Romania, where MPV values increased to 8.1 (7.5; 8.7) in the sepsis group compared to controls (22).

The calculated AUC for RDW was 0.973 with >15.2 cut off and 90.24% sensitivity, and 97.47% specificity. Similarly Kim S et al., found AUC of 0.733 for each 1% increase in RDW, the AUC for MPV was 0.966 with >9.4 cut off, sensitivity was 92.68%, and specificity was 97.47% (23). Similarly El-Said AM et al., in Egypt found a significant increase in levels of RDW and MPV and NLR (p<0.001) on admission and day three [5,24]. The AUC was 0.842, sensitivity was 89%, specificity was 85%, and 86% accuracy among septic shock patients. Another study by Varol E et al., found AUC for MPV as 0.65 and cut-off of 11.5 and AUC for NLR was 0.984 with >10.1 cut-off, 100% sensitivity and 89.87% specificity among unselected ICU patients [5,24]. Akili NB et al., found AUC of 0.61 with 11.9 cut-off similar to present study. Kaushik R et al., in India found AUC of 0.911, sensitivity was 87.5% and specificity was 90% almost similar to present study (25),(26).

The definite pathophysiologic mechanism involving changes in MPV, NLR, RDW is still uncertain. It is believed that essential components in infection cascade, inflammation, oxidative stress, nutritional deficiencies, and renal dysfunction play an important role (27). As per the study findings, there was an increase in the levels of RDW, MPV, NLR in sepsis patients. These blood parameters are quick and cost-effective that can be done even in resource stricken centers in India. The study’s main strength was its prospective nature, and also the data which was obtained by real -time clinical parameters. This data can help health care professionals in saving crucial lives by monitoring and managing of severe sepsis patients and lowering mortality rate.

Limitation(s)

The study had few limitations. Patient’s inflammatory status is dependent on CRP procalcitonin gamma-glutamyl transferase, etc. Levels of RDW, NLR, and MPV get affected by these inflammatory variables and as these were not explored in present study, Patient’s inflammatory status cannot be made. The duration between blood sampling and measuring of RDW might affect RDW levels significantly. Intraday cell count variations should have been considered to further validate the findings. This was a single centre, prospective observational study with less sample size of 120, and these results cannot be generalised to overall population.

Conclusion

This study demonstrated a strong correlation between increased levels of RDW, NLR, MPV and mortality among sepsis patients and can be used as prognostic markers for mortality prediction in adult sepsis patients. These markers showed good sensitivity, specificity and accuracy similar to other biomarkers. These markers are readily available from routine CBC test and can be evaluated quickly in less time and low cost. During early hospitalisation, these markers can be used as a specific index of haemogram in sepsis management. Further multicentric longitudinal studies with large samples are recommended to support the present study’s findings.

References

1.
Esper AM, Martin G. Extending international sepsis epidemiology: The impact of organ dysfunction. Crit Care. 2009;13(1):120. [crossref] [PubMed] [PubMed]
2.
Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014. J Am Med Assoc. 2017;318(13):1241-49.
3.
Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200-11. [crossref]
4.
Singer M, Deutschman CS, Seymour C, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). J Am Med Assoc. 2016;315(8):801-10. [crossref] [PubMed]
5.
El Said AM, Fayed AM, El-Reweny EM. Comparative study between complete blood picture indices and presepsin as early prognostic markers in septic shock patients. Egypt J Anaesth. 2020;36(1):118-25. [crossref]
6.
Orfanu AE, Popescu C, Leuştean A, Negru AR, Tilişcan C, Arama V et al. The importance of haemogram parameters in the diagnosis and prognosis of septic patients. J Crit Care Med. 2017;3(3):105-10. [crossref] [PubMed]
7.
Nagao M. A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals. Clin Microbiol Infect. 2013;19(9):852-58. [crossref] [PubMed]
8.
Gozdas HT, Gel KT, Yasayacak A, Kesgin MT, Akdeniz H. Platele T Lymphocytes Ratio Sepsis. Age (Omaha). 2019;16(3):16-22. [crossref]
9.
Chen B, Ye B, Zhang J, Ying L, Chen Y. RDW to platelet ratio: A novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B. PLoS One. 2013;8(7):e68780. [crossref] [PubMed]
10.
Lorente L, Martín MM, Abreu-González P, Solé-Violán J, Ferreres J, Labarta L. Red blood cell distribution width during the first week is associated with severity and mortality in septic patients. PLoS One. 2014;9(8):e105436. [crossref] [PubMed]
11.
Qiu L, Chen C, Li SJ, Wang C, Guo F, Peszel A, et al. Prognostic values of red blood cell distribution width, platelet count, and red cell distribution width-to-platelet ratio for severe burn injury. Sci Rep. 2017;7(1):01-07. [crossref] [PubMed]
12.
Pandya H, Pabani N, Shah K, Yadav R, Patel P, Raninga J. Study of various prognostic factors for sepsis patients requiring intensive medical care with special emphasis on APACHE II score in prognostication. J Integr Heal Sci. 2015;3:14-22. [crossref]
13.
Kim YC, Song JE, Kim EJ, Choi H, Jeong WY, Jung IY, et al. A simple scoring system using the red blood cell distribution width, delta neutrophil index, and platelet count to predict mortality in patients with severe sepsis and septic shock. J Intensive Care Med. 2019;34(2):133-39. [crossref] [PubMed]
14.
Jones AE, Trzeciak S, Kline JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med. 2009;37(5):1649-54. [crossref] [PubMed]
15.
Ferreira FL, Bota DP, Bross A, Melot C, Vincent J. Serial evaluation of the SOFA scores to predict outcome in critically ill patients. JAMA. 2001;286:1754-58. [crossref] [PubMed]
16.
BDSS Corp. Released 2020. coGuide Statistics software, Version 1.0, India: BDSS corp. Available from: https://www.coguide.in. [Last accessed on 2021 Oct 27].
17.
Lie KC, Lau CY, Van Vinh Chau N, West TE, Limmathurotsakul D. Utility of SOFA score, management and outcomes of sepsis in Southeast Asia: A multinational multicenter prospective observational study. J Intensive Care. 2018;6(1):9. [crossref] [PubMed]
18.
Krishna V, Pillai G, Sukumaran S. Red cell distribution width as a predictor of mortality in patients with sepsis. Cureus2. 2021;13(1):e12912. [crossref]
19.
Gupta A, Gupta R. Study of hematological parameters in sepsis patients and its prognostic implications. Int J Res Med Sci. 2019;7(3):828. [crossref]
20.
Pavan MR, Hande MH, Jeganathan J, Shetty M, Chakrapani M. Role of red cell distribution width and neutrophil: Lymphocyte ratio in adults with sepsis. Int J Curr Res Rev. 2021;13(3):50-53. [crossref]
21.
Liu X, Shen Y, Wang H, Ge Q, Fei A, Pan S. Prognostic significance of neutrophilto- lymphocyte ratio in patients with sepsis: A prospective observational study. Maccio A, editor. Mediators Inflamm. 2016;2016:8191254. [crossref] [PubMed]
22.
Orfanu A, Popescu C, Tilişcan C, Streinu-Cercel A, Arama V, Arama SS. The usefulness of neutrophil/lymphocyte count ratio in the diagnosis and prognosis of bacterial sepsis- An old parameter with new implications. Rev Rom Med Lab. 2020;28 (1):39-48. [crossref]
23.
Kim S, Lee K, Kim I, Jung S, Kim MJ. Red cell distribution width and early mortality in elderly patients with severe sepsis and septic shock. Clin Exp Emerg Med. 2015;2(3):155-61. [crossref] [PubMed]
24.
Varol E. Platelet indices in assessment of in hospital mortality in intensive care unit patients. J Crit Care. 2014;29 (5):864. [crossref] [PubMed]
25.
Akilli NB, Yortanl. M, Mutlu H, Gunayd.n YK, Koylu R, Akca H et al. Prognostic impor- tance of neutrophil-lymphocyte ratio in critically ill patients: short- and long-term outcomes. Am J Emerg Med. 2014;32(12):1476-80. [crossref] [PubMed]
26.
Kaushik R, Gupta M, Sharma M, Jash D, Jain N, Sinha N, et al. Diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in early and late phase of sepsis. Indian J Crit Care Med. 2018;22(9):660-63. [crossref] [PubMed]
27.
Abdelaleem NA, Makhlouf HA, Nagiub EM, Bayoumi HA. Prognostic biomarkers in predicting mortality in respiratory patients with ventilator-associated pneumonia. Egypt J Bronchol. 2021;15(1):01-08. [crossref] [PubMed]

DOI and Others

DOI: 10.7860/JCDR/2022/52240.16203

Date of Submission: Sep 05, 2021
Date of Peer Review: Sep 30, 2021
Date of Acceptance: Dec 11, 2021
Date of Publishing: Apr 01, 2022

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Sep 06, 2021
• Manual Googling: Oct 27, 2021
• iThenticate Software: Feb 11, 2022 (15%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com